A Path to BiomarkersQ&A with Jong Yoon, M.D.
Predicting the path of illness for someone diagnosed with schizophrenia is difficult because its origins are so varied. Dana Grantee Jong Yoon is developing imaging methods to tease out the cellular mechanisms of one potential cause: too much dopamine production.
Finding Clues to Schizophrenia Outside Neurons
Ariel Y. Deutch, Ph.D. James G. Blakemore Chair of Psychiatry, professor of psychiatry and pharmacology Vanderbilt University Medical Center View article as PDF In 1972 the distinguished neurologist Fred Plum famously labeled efforts to reveal structural changes in the brain in schizophrenia the “graveyard of neuropathologists.” This conclusion came on the heels of research dating […]
Schizophrenia: Hope on the Horizon
In July 2014, an international consortium of schizophrenia researchers mounted the largest biological experiment in the history of psychiatry. With many more avenues for exploring the biological underpinnings of schizophrenia now available to neuroscientists, hope may be on the way for the estimated 2.4 million Americans and 1 in 100 people worldwide affected by the illness.